Literature DB >> 19251703

Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.

Johannes H Ippel1, Carla J C de Haas, Anton Bunschoten, Jos A G van Strijp, John A W Kruijtzer, Rob M J Liskamp, Johan Kemmink.   

Abstract

Complement component C5a is a potent pro-inflammatory agent inducing chemotaxis of leukocytes toward sites of infection and injury. C5a mediates its effects via its G protein-coupled C5a receptor (C5aR). Although under normal conditions highly beneficial, excessive levels of C5a can be deleterious to the host and have been related to numerous inflammatory diseases. A natural inhibitor of the C5aR is chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS). CHIPS is a 121-residue protein excreted by S. aureus. It binds the N terminus of the C5aR (residues 1-35) with nanomolar affinity and thereby potently inhibits C5a-mediated responses in human leukocytes. Therefore, CHIPS provides a starting point for the development of new anti-inflammatory agents. Two O-sulfated tyrosine residues located at positions 11 and 14 within the C5aR N terminus play a critical role in recognition of C5a, but their role in CHIPS binding has not been established so far. By isothermal titration calorimetry, using synthetic Tyr-11- and Tyr-14-sulfated and non-sulfated C5aR N-terminal peptides, we demonstrate that the sulfate groups are essential for tight binding between the C5aR and CHIPS. In addition, the NMR structure of the complex of CHIPS and a sulfated C5aR N-terminal peptide reveals the precise binding motif as well as the distinct roles of sulfated tyrosine residues sY11 and sY14. These results provide a molecular framework for the design of novel CHIPS-based C5aR inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251703      PMCID: PMC2673304          DOI: 10.1074/jbc.M808179200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats.

Authors:  A J Strachan; T M Woodruff; G Haaima; D P Fairlie; S M Taylor
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

Review 2.  The biology and enzymology of protein tyrosine O-sulfation.

Authors:  Kevin L Moore
Journal:  J Biol Chem       Date:  2003-05-02       Impact factor: 5.157

3.  ARIA: automated NOE assignment and NMR structure calculation.

Authors:  Jens P Linge; Michael Habeck; Wolfgang Rieping; Michael Nilges
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

4.  Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data.

Authors:  E R Zuiderweg; D G Nettesheim; K W Mollison; G W Carter
Journal:  Biochemistry       Date:  1989-01-10       Impact factor: 3.162

5.  Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.

Authors:  Justin Liu; Samuel Louie; Willy Hsu; Kristine M Yu; Hugh B Nicholas; Grace L Rosenquist
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-24       Impact factor: 6.914

6.  Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.

Authors:  Bent Postma; Miriam J Poppelier; Joost C van Galen; Eric R Prossnitz; Jos A G van Strijp; Carla J C de Haas; Kok P M van Kessel
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

7.  Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.

Authors:  Darren R March; Lavinia M Proctor; Martin J Stoermer; Robert Sbaglia; Giovanni Abbenante; Robert C Reid; Trent M Woodruff; Khemar Wadi; Natalii Paczkowski; Joel D A Tyndall; Stephen M Taylor; David P Fairlie
Journal:  Mol Pharmacol       Date:  2004-04       Impact factor: 4.436

8.  Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.

Authors:  N Bannert; S Craig; M Farzan; D Sogah; N V Santo; H Choe; J Sodroski
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

9.  Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor.

Authors:  M Farzan; C E Schnitzler; N Vasilieva; D Leung; J Kuhn; C Gerard; N P Gerard; H Choe
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

10.  Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

Authors:  Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more
  15 in total

Review 1.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

2.  Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.

Authors:  Zhen-jia Liu; Yan-juan Yang; Lei Jiang; Ying-chun Xu; Ai-xia Wang; Guan-hua Du; Jin-ming Gao
Journal:  Acta Pharmacol Sin       Date:  2011-06-27       Impact factor: 6.150

3.  Isothermal titration calorimetry of membrane proteins - progress and challenges.

Authors:  Krishna Rajarathnam; Jörg Rösgen
Journal:  Biochim Biophys Acta       Date:  2013-06-05

4.  Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.

Authors:  Gregory V Nikiforovich; Thomas J Baranski
Journal:  Biochem Biophys Res Commun       Date:  2009-09-30       Impact factor: 3.575

5.  A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds.

Authors:  Anton Bunschoten; Johannes H Ippel; John A W Kruijtzer; Louris Feitsma; Carla J C de Haas; Rob M J Liskamp; Johan Kemmink
Journal:  Amino Acids       Date:  2010-08-04       Impact factor: 3.520

6.  Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation.

Authors:  Soumendra Rana; Amita Rani Sahoo
Journal:  Biochem Biophys Rep       Date:  2015-03-24

7.  Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1.

Authors:  Shinnosuke Tanaka; Toshiaki Nishiyori; Hidetaka Kojo; Reo Otsubo; Moe Tsuruta; Katsuhisa Kurogi; Ming-Cheh Liu; Masahito Suiko; Yoichi Sakakibara; Yoshimitsu Kakuta
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 8.  Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.

Authors:  Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

9.  Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction.

Authors:  Takamasa Teramoto; Yukari Fujikawa; Yoshirou Kawaguchi; Katsuhisa Kurogi; Masayuki Soejima; Rumi Adachi; Yuichi Nakanishi; Emi Mishiro-Sato; Ming-Cheh Liu; Yoichi Sakakibara; Masahito Suiko; Makoto Kimura; Yoshimitsu Kakuta
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  Synthetic Peptides as Protein Mimics.

Authors:  Andrea Groß; Chie Hashimoto; Heinrich Sticht; Jutta Eichler
Journal:  Front Bioeng Biotechnol       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.